HUNAN JINGFENG PHARMACEUTICAL CO.,LTD. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.69 CNY | +5.62% |
|
+1.81% | -47.84% |
| Sales 2022 | 841M 116M | Sales 2023 | 657M 90.74M | Capitalization | 2.85B 394M |
|---|---|---|---|---|---|
| Net income 2022 | -128M -17.68M | Net income 2023 | -215M -29.7M | EV / Sales 2022 | 3.82 x |
| Net Debt 2022 | 417M 57.66M | Net Debt 2023 | 581M 80.21M | EV / Sales 2023 | 5.22 x |
| P/E ratio 2022 |
-21.8
x | P/E ratio 2023 |
-13.3
x | Employees | 645 |
| Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 83.26% |
More Fundamentals
* Assessed data
More news
| 1 day | +5.62% | ||
| 1 week | +1.81% | ||
| 1 month | -28.69% | ||
| 3 months | -9.63% | ||
| 6 months | -48.94% | ||
| Current year | -47.84% |
1 week
1.55
1.69
1 month
1.482.20
Current year
1.253.34
1 year
1.253.99
3 years
1.257.35
5 years
1.258.45
10 years
1.2524.55
| Managers | Title | Age | Since |
|---|---|---|---|
Xiang Wu Ye
FOU | Founder | 72 | 98-12-08 |
Yuan Bi
BRD | Director/Board Member | 36 | 18-07-19 |
Min Chen
IRC | Investor Relations Contact | 45 | - |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Xiang Wu Ye
FOU | Founder | 72 | 98-12-08 |
Xiong Wen Hu
BRD | Director/Board Member | 58 | 14-12-28 |
Yuan Bi
BRD | Director/Board Member | 36 | 18-07-19 |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-04-29 | 1.69 | +5.62% | 42,045,610 |
| 24-04-26 | 1.6 | -3.61% | 33,577,480 |
| 24-04-25 | 1.66 | +5.73% | 34,911,030 |
| 24-04-24 | 1.57 | -1.26% | 22,192,620 |
End-of-day quote Shenzhen S.E., April 28, 2024
More quotes
Hunan Jingfeng Pharmaceutical Co.,Ltd., formerly Hunan Tianyi Science and Technology Co., Ltd, is a China-based company principally engaged in the research, development, manufacture and sale of chemical drugs, biochemical drugs and traditional Chinese patent drugs. The Company's main products includes cardio and cerebrovascular drugs, antihypertensive and hypolipidemic drugs, orthopedic drugs, anti-tumor products, endocrine drugs, digestive system drugs, antiviral drugs and anti-infective drugs, among others. The Company is also involved in commodity import and export trading, business management and consulting, as well as medical technology consulting business. The Company distributes its products in the domestic market.
Sector
Pharmaceuticals
Calendar
2024-08-25
- Q2 2024 Earnings Release (Projected)
Annual profits - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| -47.84% | 205M | |
| +26.08% | 681B | |
| +21.85% | 556B | |
| -4.77% | 361B | |
| +16.97% | 325B | |
| +5.69% | 285B | |
| +13.68% | 235B | |
| +3.65% | 199B | |
| -11.12% | 189B | |
| -3.40% | 157B |
- Stock Market
- Equities
- 000908 Stock
